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Abstract
NIH-PA Author Manuscript

Background—Surgical and perioperative improvements permit earlier repair of partial and
transitional atrioventricular septal defects (AVSD). We sought to describe contemporary outcomes
in a multicenter cohort.
Methods—We studied 87 patients undergoing primary biventricular repair of partial or transitional
AVSD between June 2004 and February 2006 across seven North American centers. One-month and
6-month postoperative data included weight-for-age z-scores, left atrioventricular valve regurgitation
(LAVVR) grade, residual shunts, and left ventricular ejection fraction. Paired methods were used to
assess 6-month change.
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Results—Median age at surgery was 1.8 years; median weight z-score was −0.88. Median days for
ventilation were 1, intensive care 2, and hospitalization 5, all independent of age, with 1 in-hospital
death. At 1 month, 27% (16 of 73) had ejection fraction less than 55%; 20% (17 of 87) had significant
LAVVR; 2 had residual shunts; 1 each had subaortic stenosis and LAVV stenosis. At 6 months (n =
60), there were no interim deaths, reinterventions, or new development of subaortic or LAVV
stenosis. Weight z-score improved by a median 0.4 units (p < 0.001), especially for underweight
children less than 18 months old. Left atrioventricular valve regurgitation occurred in 31% (change
from baseline, p = 0.13), occurring more frequently in patients repaired at 4 to 7 years (p = 0.01).
Three patients had ejection fraction less than 55%, and 1 had a residual atrial shunt.
Conclusions—Surgical repair for partial/transitional AVSD is associated with low morbidity and
mortality, short hospital stays, and catch-up growth, particularly in underweight children repaired
between 3 and 18 months of age. Left atrioventricular valve regurgitation remains the most common
residual defect, occurring more frequently in children repaired after 4 years of age.
Children with partial and transitional atrioventricular septal defect (AVSD) are largely
asymptomatic so referral for surgical repair is typically delayed to preschool or older ages
[1-5]. Recently, single centers have reported good results in younger children [6]. Although
there may be theoretical advantages to earlier repair, such as minimizing the child’s exposure
to pulmonary overcirculation and right heart volume overload, these factors must be weighed
against the potential for unfavorable outcomes in the younger child. The purpose of this study
was to describe contemporary outcomes after repair of partial or transitional AVSD in a
multicenter cohort.
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Patients and Methods
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Between June 2004 and February 2006, echocardiographic and clinical data were collected on
children undergoing primary biventricular repair of a partial or transitional AVSD
uncomplicated by anomalous pulmonary venous connection across the seven North American
centers (Appendix) comprising the Pediatric Heart Network. All participating centers received
Institutional Review Board approval (clinicaltrials.gov identifier NCT00113698), and this
study was funded by the National Heart, Lung, and Blood Institutes (NHLBI). As part of a
planned drug trial evaluating the use of angiotensin-converting enzyme (ACE) inhibitors in
children with left atrioventricular valve regurgitation (LAVVR) after AVSD repair,
consecutive children with parent/guardian consent were enrolled into an observation-only
phase for 6 months postoperatively to allow the heart to adapt to surgical intervention. During
this 6-month period, prospective clinical and echocardiographic data were collected for 60 of
the 87 patients in this analysis. To report outcomes representative of the entire disease spectrum,
we added all screened patients in our database from the same time period who met clinical
exclusion criteria for the trial (e.g., planned reoperation, left atrioventricular valve [LAVV]
stenosis) to the analysis cohort. These patients had demographic characteristics similar to those
who had been enrolled in the observation phase of the study. The data for these additional
patients were obtained retrospectively under waiver of consent approval. An NHLBI-appointed
Data and Safety Monitoring Board monitored the conduct of the study.
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Definitions
Published definitions of AVSD subtypes vary. For the present study, partial AVSD was
characterized by an ostium primum atrial septal defect (ASD) with intact ventricular septum;
a transitional AVSD was characterized by an ostium primum ASD, two-orifice atrioventricular
valve, and restrictive inlet ventricular septal defect (VSD) [7,8]. Since both partial and
transitional AVSD result in right heart volume overload with little or no ventricular level shunt,
data from children with either defect were combined for this analysis.
Clinical and Surgical Data Collection
Data were collected at surgery, within 1 month of surgery, and at 6 months after surgery.
Operative reports from all patients were independently reviewed for uniformity in defect
classification and details of repair by three investigators blinded to outcomes. Annuloplasty
included any additional left atrioventricular valve surgery beyond cleft closure that involved
reduction in the annulus size.
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Sex, presence of trisomy 21, associated defects, age and weight at surgery, complications
requiring a change in therapy, and duration of mechanical ventilation, intensive care, and total
hospitalization were obtained from medical records. Weight-for-age z-scores were calculated
using sex-specific reference values for trisomy 21 [9] and normal children [10,11], as
appropriate. For normal children, weight-for-age z-scores were calculated using both World
Health Organization [10] and Centers for Disease Control [11] data. Because results were
similar and all inferences the same, only Centers for Disease Control data are reported. Patients
with weight z-score of −2 or less were considered to have growth failure. Heart failure scores
were obtained 6 months after surgery using the Ross heart failure classification [12] or New
York Heart Association (NYHA) [13] classification, as age appropriate. Cardiac medications
were recorded at the time of the echocardiograms.
Echocardiographic Data
For patients enrolled prospectively, echocardiograms were performed within 1 month after
repair and at 6-month follow-up using a standard protocol and sent to a core laboratory where
measurements were made by a single observer. For patients enrolled retrospectively, only 1Ann Thorac Surg. Author manuscript; available in PMC 2010 July 9.
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month echocardiograms were available with all measurements made by each center’s
echocardiographers. Left ventricular ejection fraction (LVEF) was calculated using Simpson’s
rule or the area/length method [14]. Left ventricular (LV) dysfunction was defined as an LVEF
less than 55%. The LAVVR was subjectively graded as none/trace, mild, moderate, or severe
based on the appearance of the color Doppler jets in relation to the surrounding chambers
[1-5]. The LAVVR was considered significant if graded as moderate or worse. Color Doppler
was also used to demonstrate a residual ASD or VSD, and diameters more than 3 mm were
considered significant [15]. Pulsed Doppler interrogation was used to evaluate LAVV inflow
and LV outflow: LAVV mean gradient of 7.5 mm Hg or more and LV outflow peak
instantaneous gradient of 20 mm Hg or more were considered significant.
Statistical Analysis
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Patient characteristics by type of defect were compared using Fisher’s exact test for categorical
variables, the Wilcoxon rank sum test for positively skewed variables, and a t test for all other
continuous variables. Descriptive statistics are reported as mean ± SD unless otherwise noted.
Crude analysis of 6-month change in categorical outcomes was conducted with McNemar’s
test. Six-month change in continuous outcomes was analyzed using a paired t test. Linear
regression was employed to identify independent predictors of 6-month change in weight-forage z-score. Nonparametric generalized additive modeling was used to identify nonlinear
associations between covariates and outcomes. Logistic regression was used to identify
surgical correlates of preoperative LAVVR grade and predictors of the presence of moderate
or greater LAVVR at 6 months after surgery. All variables significant at the 0.20 level in
univariate analysis were evaluated for inclusion in multivariate models for change in weight
z-score and for the presence of moderate or greater LAVVR 6 months after surgery.

Results
Subjects
The group for this analysis (Table 1) included 87 patients (60 partial; 27 transitional). Most
were white (82%), 33% had trisomy 21, and 51% were male. The median age at repair was 1.8
years, with 26 of 87 (30%) repaired at less than 1 year, and 3 at less than 3 months (Fig 1).
Weight z-scores at surgery ranged from −6.8 to 6.2 (median −0.88). Patients with partial AVSD
underwent repair significantly later than patients with transitional defects, but their weight zscores were similar. Weight z-score of −2 or less (growth failure) was present in 17 of 87 (20%).
At least moderate LAVVR was present on the preoperative echocardiogram in 31 of 87 (36%).
The most common associated defect noted at surgery (Table 2) was an additional atrial level
shunt (53 of 87 patients, 61%).
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Operative Data
Of the 27 patients with transitional AVSD, 26 underwent VSD closure. Cleft closure was
performed in 86 of 87 patients (99%) and annuloplasty in 22 of 87 (25%, including 16 partial
and 6 transitional AVSD). Annuloplasty was associated with the presence of significant
LAVVR on the preoperative echocardiogram: 42% of patients with moderate or greater
LAVVR on the preoperative echocardiogram underwent annuloplasty, compared with 16%
who had none/trace or mild preoperative LAVVR (odds ratio [OR] 3.77, 95% confidence
interval [CI]: 1.38 to 10.34, p = 0.01). There was no significant variation in annuloplasty use
among centers (p = 0.30).
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Outcome Data Less Than 1 Month Postoperative
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There was 1 in-hospital death (1%), of a 4-day-old infant who underwent arch reconstruction
in addition to partial AVSD repair. This infant also had repeat valvuloplasty for low cardiac
output and progressive LAVVR and subsequently died of multiorgan failure.
Median days for mechanical ventilation were 1 (range, 0 to 73), intensive care stay 2 (range,
1 to 83), and hospitalization 5 (range, 3 to 90); and all were independent of age at surgery (p
= not significant). We identified 20 complications that required change in therapy (Table 3).
Within 1 month (6.9 ± 6.7 days) after surgery, 20 of 73 (27%) had LV dysfunction and 17 of
87 (20%) had moderate or greater LAVVR. Three underwent repeat valvuloplasty before
discharge. Left atrioventricular valve stenosis (mean gradient 8 mm Hg), subaortic stenosis
(peak gradient 39 mm Hg), residual ASD, and residual VSD occurred in 1 patient each.
Medications noted at the first postoperative echocardiogram included diuretics in 84%, ACE
inhibitor in 8% (5 patients with moderate or greater LAVVR, 2 with LV dysfunction), and
digoxin and beta-blocker in 1 child with LV dysfunction (LVEF 47%).
Outcome Data 6 Months Postoperative
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The 67 prospective patients included 1 in-hospital death and 6 who failed to return for followup. In addition, 1 early postoperative echocardiogram was uninterpretable by the core
laboratory, preventing paired analysis. Thus, echocardiographic and clinical data pairs were
available for 59 and 60 of 87 patients, respectively, with mean follow-up at 6.4 ± 0.8 months.
In the interim, there were no deaths or reinterventions, and no additional patients had subaortic
or LAVV stenosis. A residual ASD (4 mm) was present in 1 patient, and the 1 residual VSD
had spontaneously closed. Six months after surgery, 3 of 59 patients had mild LV dysfunction
(LVEF ≥ 51% for all 3). The prevalence of diuretic use decreased to 10% (p < 0.001), ACE
inhibitor use (7%) was similar to use less than 1 month after repair, and no patient was using
digoxin or beta-blocker. Using Ross (n = 55) or NYHA (n = 5) heart failure scores, 58 patients
were functional class I, and 2 were class III—both had transitional AVSD and severe LAVVR.
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WEIGHT GAIN AND AGE AT SURGERY—Weight z-scores showed a significant increase
(median z-score change of 0.4, p < 0.001), and the 6-month postoperative change was loglinearly related to age at surgery. Children who underwent surgery before age 18 months had
the largest gains. We aimed to identify all independent predictors of weight gain and found an
interaction between continuous log(age) and preoperative weight z-score (p = 0.002). Weight
improvement was only associated with younger age at surgery for children with lower weight
z-scores: in particular, those with z-score of −1 or less (Fig 2). There was no association
between age at surgery and weight gain for patients with preoperative weight z-scores of −1.0
or greater. Change in weight z-score was unrelated to the presence of trisomy 21 and defect
type. At 6 months after surgery, there was also a decrease in the prevalence of growth failure
to 8% (5 of 60). Of these 5 children with weight z-scores of −2 or less, 4 had significant
LAVVR.
LAVVR AND AGE AT SURGERY—The prevalence of moderate or greater postoperative
LAVVR did not change significantly over time (Fig 3): 20% (12 of 59) at less than 1 month
and 31% at 6 months after surgery (18 of 59, p = 0.13) with a higher rate for older children
(Fig 4). Significant LAVVR 6 months after surgery occurred in 8 of 9 children (89%) repaired
between ages 4 and 7 years compared with 11 of 50 (22%) repaired at less than 4.0 years or at
7 or more years (nonlinearity p = 0.01). This finding persisted even after adjustment for 1month postoperative LAVVR status. Significant LAVVR at 6 months was associated with
moderate or greater LAVVR within 1 month of surgery (OR 4.59, 95% CI: 1.21 to 17.24, p =
0.03) but had no independent association with weight, defect type, double orifice or parachute
LAVV, annuloplasty, cleft closure, or trisomy 21. Even after adjustment for significant

Ann Thorac Surg. Author manuscript; available in PMC 2010 July 9.
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LAVVR within 1 month of surgery, the presence of moderate to severe LAVVR at 6 months
was marginally associated with preoperative moderate to severe LAVVR (adjusted OR 3.18,
95% CI: 0.94 to 10.70, p = 0.06). Of patients with none/trace or mild LAVVR 6 months after
surgery, 29% had moderate or greater LAVVR on the preoperative study. In contrast, of
patients with moderate or severe LAVVR 6 months postoperatively, 56% had moderate or
greater LAVVR preoperatively. Of the 8 children aged 4 to 7 years with moderate to severe
LAVVR at 6-month follow-up, 5 had at least moderate LAVVR on the preoperative
echocardiogram.

Comment
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Our data indicate that repair of partial or transitional AVSD before preschool ages may be
advantageous for improving weight gain and for LAVV function. This multi-institutional study
is unique in exploring the improvement in growth after repair of a partial or transitional AVSD.
Although poor weight gain is a common indication for surgery in patients with a complete
AVSD, it is not the typical reason for repairing the partial or transitional subtypes. Surprisingly,
however, 20% of this study population met the definition of growth failure at the time of
surgery, and the prevalence dropped to 8% 6 months after repair. In addition, primarily among
patients less than 18 months old with preoperative weight z-scores of −1.0 or less, there was
a significant increase in weight z-score at 6 months after surgery that was independent of the
presence of trisomy 21 and defect type.
Outcomes in this contemporary cohort of children who were repaired at a median of 1.8 years
of age were generally good. In-hospital mortality was low (1%) and comparable to recent
single-center reports of approximately 2% [1,3,8]. Ventilator, intensive care, and hospital days
were short and independent of age at repair. Symptomatic infants with partial AVSD who
require repair within the first few months of life are known to be higher risk [16], but with only
3 infants younger than 3 months of age, this study was not powered to evaluate the lower bound
for repair.
Residual shunts were rare (1% or less) in this cohort, comparing favorably with single-center
reports. Residual ASDs have been reported in 0% to 4%, rarely needing reoperation [5,15] and
tend to result from sutures near the atrioventricular conduction system being placed excessively
shallow to avoid damaging it. The VSDs may remain after repair of a transitional AVSD when
shunts through dense chordal attachments are not addressed in an attempt to avoid distorting
valve motion. When surgical closure is attempted and a small ventricular shunt remains, it is
likely to close spontaneously [17], as shown here.
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One patient had subaortic stenosis during early follow-up. Other investigators report a
prevalence of subaortic stenosis of 5% after AVSD repair, with the majority (approximately
60%) of cases occurring in the partial or transitional forms where attachment of the LAVV
leaflet to the ventricular crest further encroaches on an already narrowed LV outflow tract
[18]. Because subaortic stenosis may develop over time, the 6-month follow-up for this cohort
may not be long enough to allow an accurate estimation of the prevalence of this lesion.
Left ventricle dysfunction typically improves after AVSD repair [5], consistent with our
finding that only 3 patients had mild LV dysfunction at 6-month follow-up.
Despite the improvement in mortality and other morbidities, there has been little impact on the
prevalence of significant postoperative LAVVR in the recent surgical era. The 20% to 31%
prevalence of moderate to severe LAVVR after repair of partial/transitional AVSD in our group
appears similar to that in other reports where ranges are given from 15% to 50% at a median
age of repair ranging from 3.6 to 5.3 years [1-6]. Some reports do not consistently discriminate
between partial/transitional and complete AVSD, however, prohibiting direct comparisons
Ann Thorac Surg. Author manuscript; available in PMC 2010 July 9.
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with our data. Murashita and colleagues [3] reported 30% of patients with partial/transitional
AVSD (median repair age 5.3 years) had at least grade II (scale range, I to IV) LAVVR at
hospital discharge that increased to 43% at mean follow-up of almost 9 years. Data from Aubert
and colleagues [4] showed LAVVR grade II or higher in 26% of repaired partial AVSD patients
(median repair age 5.8 years), with 2.9% having repeat valvuloplasty within 30 days,
comparable to our early reoperation rate of 3.4%.
Although the data conflict, potential risk factors reported for significant LAVVR after AVSD
repair include partial AVSD, absence of trisomy 21, significant preoperative LAVVR, younger
age at repair, incomplete or no cleft closure, technique of repair, and double orifice or parachute
LAVV [3,6,8,19]. We examined each of these factors and found none predicted significant
postoperative LAVVR in this cohort. Although the presence of moderate or greater
preoperative LAVVR rendered a threefold risk of significant postoperative LAVVR, the wide
confidence interval reflected the clinical variation. We found that moderate or greater LAVVR
within 1 month after surgery predicted moderate to severe LAVVR at 6-month follow-up,
indicating that early postoperative regurgitation was unlikely to resolve. The prevalence of
moderate or greater LAVVR at 6-month follow-up was significantly higher among patients
having repair between 4 and 7 years of age. Although annuloplasty has been reported to
improve LAVV function [20], it was not associated with a decrease in the prevalence of
significant LAVVR in this cohort.
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It is not clear why LAVVR remains the most common residual lesion after AVSD repair. Some
investigators postulate that despite individualizing each case, alterations in geometry and
rotation of the axis of closure combined with deficient and dysplastic subvalvar components
may leave some of these valves incompetent, despite the advances in valvuloplasty that have
been achieved in the recent era [2,4,21]. Because valve regurgitation is progressive, the effects
of relatively longstanding significant LAVVR may be another contributing factor. Significant
LAVVR results in LV volume overload, annular dilation, and remodeling of the LV from a
prolate ellipse to a more spherical and mechanically disadvantaged shape. A positive feedback
loop exists between LV dilation and LAVVR severity, leading to parallel augmentation of both
[22]. In these circumstances, earlier repair may prevent the geometric alterations of the valve
and LV and improve surgical results. It is possible that several factors may play a role in
persistent LAVVR after AVSD repair, but this study was not designed or powered to test these
hypotheses.
Study Limitations
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Because our data were collected both prospectively and retrospectively, all measurements
could not be standardized or centrally interpreted, and 6-month postoperative
echocardiographic data were not available for some subjects. In addition, the available number
of 6-month echocardiographic and clinical data pairs limited our power to detect some
associations. Finally, reliable, validated echocardiographic methods for quantitative evaluation
of LAVVR grade are not available for children, particularly in the setting of multiple and
eccentric jets characteristic of the repaired AVSD valve. We chose to use qualitative assessment
of the color Doppler jet, as this was the standard for clinical decision making at all seven centers,
and it allowed comparisons with previously published reports where it was the most commonly
used method for grading LAVVR.
In conclusion, surgical repair for partial/transitional AVSD in the current era is associated with
low morbidity and mortality. Children with preoperative weight z-scores of −1.0 or less
repaired between 3 and 18 months had the most catch-up growth, without increasing their risk
of significant LAVVR or other morbidities and without prolonging ventilation, intensive care,
or hospital days. Significant LAVVR remains the most common adverse outcome, occurring
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more frequently in patients repaired at 4 years of age or older. Future studies should explore
strategies to improve valve function in these patients.
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Appendix
North American Centers Comprising the Pediatric Heart Network
National Heart, Lung, and Blood Institute
Gail Pearson, Victoria Pemberton, Rae-Ellen Kavey, Mario Stylianou, and Marsha Mathis.

Network Chair: University of Texas Southwestern Medical Center, Lynn
Mahony
Data Coordinating Center
New England Research Institutes, Lynn Sleeper (primary investigator), Steven Colan, Gloria
Klein, Dianne Gallagher, Minmin Lu, and Paul Mitchell.
Clinical Site Investigators
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Children’s Hospital Boston: Jane W. Newburger (primary investigator), Ashwin Prakash,
Renee Margossian, Jami Levine, Ellen McGrath, and Carolyn Dunbar-Masterson; Children’s
Hospital of New York: Wyman Lai (primary investigator), Seema Mital (currently at Hospital
for Sick Children, Toronto), William Hellenbrand, Marc Richmond, Beth Printz (currently at
Rady Children’s Hospital, San Diego), Darlene Servedio, and Rosalind Korsin; Children’s
Hospital of Philadelphia: Victoria L. Vetter (primary investigator), Meryl Cohen, Sandra
DiLullo, and Marisa Nolan; North Carolina Consortium: Duke University, East Carolina
University, Wake Forest University: Page A. W. Anderson (primary investigator), deceased,
Jennifer Li (primary investigator), Wesley Covitz, Kari Crawford, Michael Hines, James
Jaggers, Charlie Sang, Jr, Lori Jo Sutton, and Mingfen Xu; Medical University of South
Carolina: J. Philip Saul (primary investigator), Andrew Atz, Girish Shirali, and Jennifer Young;
Primary Children’s Medical Center and the University of Utah: L. LuAnn Minich (primary
investigator), John A. Hawkins, Linda M. Lambert, and Richard V. Williams; Hospital for Sick
Children, Toronto: Brian McCrindle (primary investigator), Fraser Golding, Nancy Slater, and
Elizabeth Radojewski.
Echocardiography Core Laboratories
Children’s Hospital of Boston: Steven Colan and Ron Lacro.
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Protocol Review Committee
Michael Artman (Chair), Daniel Bernstein, Christopher A. Caldarone, Timothy Feltes, Julie
Johnson, Jeffrey Krischer, and G. Paul Matherne.
Data and Safety Monitoring Board
John Kugler (Chair); David J. Driscoll, Kathryn Davis, Sally A. Hunsberger, Mark
Galantowicz, Thomas J. Knight, James Tweddell, Catherine L. Webb, and Lawrence Wissow.
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ACE

angiotensin-converting enzyme

ASD

atrial septal defect

AVSD

atrioventricular septal defect

CI

confidence interval

LAVV

left atrioventricular valve

LAVVR

left atrioventricular valve regurgitation

LV

left ventricle

LVEF

left ventricular ejection fraction

NHLBI

National Heart, Lung, and Blood Institute

NYHA

New York Heart Association

OR

odds ratio

VSD

ventricular septal defect
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Fig 1.

Distribution of age (years) at repair of partial/transitional atrioventricular septal defect. Median
age at repair is 1.8 years.
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Fig 2.

(A) Scatterplot of 6-month change in weight z-score by age at surgery and preoperative weight
z-scores. Pearson correlations versus log(age) = 0 (n = 36) and −0.44 (n = 24) for subjects with
preoperative weight z-scores −1.0 or less (black) and greater than 1.0 (blue), respectively.
Regression was based on all subjects with paired data, but is truncated at age 6.4 years (oldest
subject after exclusion of 16-year-old outlier). (B) Predicted change (6 months minus
preoperation) in weight-for-age z-score at surgery and preoperative weight z-score. Log(age)
by preoperative weight-for-age z-score interaction p = 0.002; R2 = 0.40. The association with
log(age) is significant only when weight z-score is −1 or less. The hatch lines at the bottom of
the plot represent the observed ages in the dataset. Modeling was based on all subjects with 6month data, but the plot is truncated at age 6.4 years, (oldest subject after exclusion of 16-yearold outlier).
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Change in moderate or greater left atrioventricular valve regurgitation (LAVVR) from
preoperation and less than 1 month after operation to 6 months after operation (n = 59;
McNemar test p values = 0.37 and 0.13). “Resolved,” “no change,” and “developed” refer to
the presence of moderate or greater LAVVR.
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Estimated probability of moderate or greater left atrioventricular valve regurgitation (LAVVR)
6 months after repair (n = 60; test of nonlinearity p = 0.01). Of 9 children repaired at 4 to 7
years of age, 8 had moderate or greater LAVVR (89%) at 6-month follow-up. The hatch lines
at the top and bottom of the plot represent the ages at surgery of the patients who had and did
not have, respectively, moderate or greater LAVVR. Modeling was based on all subjects with
6-month data, but the plot is truncated at age 7 years (oldest subject aged 16 years not shown).
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Median age in years at repair (range)a

n

87
87

Trisomy 21

Moderate or greater preoperative LAVVR

36%

33%
60

60
32%

29%

10%

5%
59

8%

Other/unknown
10%

2%

1%

Asian

86

7%

9%

Black

Hispanicb

87%

−0.75 (−6.8 to 3.0)

3.1 (0.01 to 16.7)

55%

Partial

82%

60

60

60

60

White

Race

−0.88 (−6.8 to 6.2)

1.8 (0.01 to 16.7)

51%

All

Hispanic ethnicity unknown for 1 subject. LAVVR = left atrioventricular valve regurgitation.

b

Partial versus transitional p < 0.001 for age at repair; no other comparisons significant at the 0.05 level.

a

87

Male

87

87

Number

Median weight-for-age z-score at surgery (range)

n
87

Variable

27

27

27

27

27

27

27

n

41%

Transitional

44%

44%

11%

15%

0%

15%

70%

−0.88 (−5.7 to 6.2)

0.8 (0.3 to 4.8)
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Associated

Defectsa

Noted at Surgery

Associated Defect

n

% (n = 87)

Additional atrial shunt

53

61

Patent ductus arteriosus

10

12

Persistent left superior vena cava

3

3

Subaortic stenosis

2

2

Double orifice mitral valve

2

2

Parachute mitral valve

2

2

Coarctation of the aorta

1

1

Additional ventricular septal defect

1

1

Congenital complete heart block

1

1

a

Defects are not mutually exclusive.
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Table 3

Complications Requiring Change in Therapy
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Complicationa

n

% (n = 87)

Infection

6

7

4

5

4

5

Pericardial effusion

2

2

Intubated >2 weeks postoperatively

2

2

Pneumothorax

1

1

Bloody stool (transfused)

1

1

Bacterial positive sepsis (3)
Viral positive (2)
Pleural effusions
Nonchylous (3)
Chylous (1)
Transient arrhythmias
Ventricular tachycardia (2)
Junctional tachycardia (1)
Complete heart block (1)
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a

Complications are not mutually exclusive.
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